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Extraction, selection and comparison of features for an effective 
automated computer-aided diagnosis of Parkinson’s disease based 
on [123I]FP-CIT SPECT images 
 
Abstract 
Purpose This work aimed to assess the potential of a set of features extracted from 
[123I]FP-CIT SPECT brain images to be used in the computer-aided “in vivo” 
confirmation of dopaminergic degeneration and therefore to assist clinical decision to 
diagnose Parkinson’s disease. 
Methods Seven features were computed from each brain hemisphere: five standard 
features related to uptake ratios on the striatum and two features related to the estimated 
volume and length of striatal region with normal uptake. The features were tested on a 
dataset of 652 [123I]FP-CIT SPECT brain images from the Parkinson’s Progression 
Markers Initiative. The discrimination capacities of each feature individually and groups 
of features were assessed using three different machine learning techniques: support 
vector machines (SVM), k-nearest neighbours and logistic regression. 
Results Cross-validation results based on SVM have shown that, individually, the features 
that generated the highest accuracies were the length of the striatal region (96.5%), the 
putaminal binding potential (95.4%) and the striatal binding potential (93.9%) with no 
statistically significant differences among them. The highest classification accuracy was 
obtained using all features simultaneously (accuracy 97.9%, sensitivity 98%, and 
specificity 97.6%). Generally, slightly better results were obtained using the SVM with 
no statistically significant difference to the other classifiers for most of the features. 
4 
Conclusions The length of the striatal region uptake is clinically useful and highly 
valuable to confirm dopaminergic degeneration "in vivo" as an aid to the diagnosis of 
Parkinson’s disease. It compares fairly well to the standard uptake ratio-based features, 
reaching, at least, similar accuracies and is easier to obtain automatically. Thus, we 
propose its day to day clinical use, jointly with the uptake ratio-based features, in the 
computer-aided diagnosis of dopaminergic degeneration in Parkinson’s disease. 
 
Keywords DaTSCANTM; uptake ratios; dimensional-based features; classification; PPMI 
database. 
 
Introduction 
Parkinson’s disease (PD) is a progressive neurological disorder characterized by tremor, 
rigidity, and bradykinesia associated with progressive dopaminergic neuronal loss 
projecting into the striatum originated from the substantia nigra and other brain structures 
[1]. 
The progressive degeneration of nigrostriatal dopaminergic neurons can be assessed by 
using radioligands in imaging-based approaches. Dopamine transporters (DAT) loss in 
the presynaptic terminals of the nigrostriatal pathway is a key feature of PD. Imaging of 
the DAT with [123I]FP-CIT (commercially available as DaTSCANTM) and Single Photon 
Emission Tomography (SPECT) is the most widely used Nuclear Medicine technique for 
routine confirmation of dopaminergic degeneration during the assessment of patients with 
suspected degenerative Parkinsonism [2]. With this technique, the reduction of dopamine 
transporters can be observed in patients with PD, Multisystem Atrophy, Progressive 
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Supranuclear Palsy, Corticobasal Degeneration and also in patients with dementia with 
Lewy bodies [3-4]. The reduction of [123I]FP-CIT specific uptake in the putamen confirms 
PD and excludes the diagnosis of other diseases running with no dopaminergic 
degeneration, such as essential tremor or drug-induced Parkinsonism [5]. Frequently, 
results are based on qualitative visual evaluation, although several quantification methods 
have been developed and proposed for more objective assessments [6]. 
Striatal uptake ratios computed from the [123I]FP-CIT SPECT brain images have been 
used for image classification [7-14] often using each ratio individually. The use of 
machine learning techniques can improve the automated classification accuracy, since 
discriminative features can be simultaneously used to build a more robust 
multidimensional classification model than the models based on a single feature. 
The main goal of this work was to evaluate the potential of several features (individually 
and in groups) extracted from [123I]FP-CIT SPECT brain images to detect and confirm 
dopaminergic degeneration and therefore, to assist a clinical decision for the diagnosis of 
PD. Hence, three machine learning based classifiers were used: support vector machines 
(SVM), k-nearest neighbour (k-NN) and logistic regression (LR). Seven features 
automatically extracted from the images were considered: five standard features related 
to uptake ratios in the striatum, and two features related to the length and volume of the 
striatal region with normal uptake. 
The dimensions of the striatal uptake region, especially the length from the caudate head 
(most anterior) to the most posterior putamen contours, are key factors in the visual 
assessment of the [123I]FP-CIT SPECT brain images made by physicians. However, as 
far as the authors know, no work has been reported using these dimensional SPECT-DAT 
biomarkers and their automatic extraction from the images for classification. Thus, the 
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development of an effective and robust computational algorithm to extract these 
dimensional features was another goal of this work. 
 
Material and methods 
Dataset 
Data for this article were obtained from the Parkinson’s Progression Markers Initiative 
(PPMI) database (www.ppmi-info.org/data) available on August 10, 2015. The dataset 
contained all 652 pre-processed [123I]FP-CIT SPECT brain images acquired at the 
Screening stage, for the groups: control female (73 images), control male (136 images), 
PD female (157 images) and PD male (286 images). Overall, the healthy control (HC) 
subjects' age was 61.8±11.3 years old, and the PD subjects' age was 61.7±9.7 years old. 
No statistically significant difference was found between the age of the HC and PD 
patients (Student t-test, p = 0.320). 
PPMI is a longitudinal, multicentre study to assess the progression of clinical features, 
imaging and biologic markers in PD patients and HC. All the PD subjects were at an early 
stage of the disease, Hoehn and Yahr stage I or II at baseline, with a PD diagnosis obtained 
less than or equal to 2 years at Screening. PD subjects had a confirmation from imaging 
core that screening dopamine transporter SPECT scan is consistent with dopamine 
transporter deficit. All subjects were assessed at the baseline and every three to six months 
thereafter (further details of the inclusion and exclusion criteria can be found at the Study 
Protocol at http://www.ppmi-info.org/study-design/research-documents-and-sops/). 
Since different imaging systems were used, the imaging acquisition protocol was 
standardized at each clinical site, and customized study phantoms were used to enable an 
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ongoing assessment of each camera [15]. SPECT scans lasted for 30 to 45 minutes and 
started 3.5 to 4.5 hours post injection of an activity between 110 to 185 MBq. The raw 
projection data was transferred to the imaging core lab and then iteratively reconstructed, 
using a hybrid ordered-subsets expectation maximization (OSEM) algorithm in a 
HERMES workstation (Hermes Medical Solutions, Sweden). The reconstructed images 
were then transferred to the PMOD software (PMOD Technologies, Zurich, Switzerland) 
for subsequent processing, and for attenuation correction. The final pre-processed images 
were saved in a DICOM format using 91´109´91 cubic voxels with 2 mm width. 
Automated quantification 
The quantification process developed can be divided into the following main sequential 
steps (Figure 1): template-based image registration [16], i.e. alignment of the image under 
study with a pre-built 3D [123I]FP-CIT SPECT brain template image; definition of the 
regions of interest (ROIs); computation of the striatal uptake ratios; building of the voxel-
wise binding potential image and assessment of the dimensions of the striatal uptake 
region; and finally, assembly of the feature vectors to be used in the classification. 
Image registration 
We used a registration algorithm validated in a previous study [17]. This algorithm is 
based on the iterative minimization of the sum of squared differences between the image 
under study and a [123I]FP-CIT SPECT brain images template, using a rigid geometric 
transformation. The optimizer chosen is the Powell's method with the Brent's method 
available in the Insight Toolkit (ITK) software library [18]. Just for image registration 
step, the SPECT images of the patients are intensity normalized by the 99th percentile. 
The template has the orientation of the MNI space. 
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The registered images are resampled with a width of 2.2 mm, which is approximately half 
the voxel width normally used in routine clinical reconstruction of [123I]FP-CIT SPECT 
images. 
Definition of the volumetric ROI 
The automated computation of the uptake ratios is based on the counts inside the 
volumetric ROIs placed over the registered image under study. Seven ROIs are defined 
and used: a large ROI over the whole nonspecific brain region that is used as the reference 
region, and three ROIs on each hemisphere of the brain: one over the putamen, one over 
the caudate, and one large ROI containing the entire striatum and surrounding area 
(Figures 2 and 3). 
The definition of the reference ROI and the large ROI over the striatum are based on the 
work of Tossici-Bolt et al [19]. However, in the present work, all procedures are 
performed in 3D; while the original work was performed in a 2D image built from adding 
a set of transaxial slices that contained the striatum. 
The large ROIs (one on each hemisphere) over the striatum are 44 mm thick (inferior-
superior plane), 44 mm wide (left-right plane), 62 mm long (posterior-anterior plane), 
with the shape shown in Figure 2. These ROIs were defined to be large enough to take 
into account the partial volume effects and inter-subject shape variations. 
In the dataset used, there were some situations when the ROIs over the striatum were not 
totally inside the external contours of the brain. In these cases, the voxels outside the brain 
were excluded. This occurred with subjects who had very small heads and when the 
original image did not contain the whole brain due to image acquisition flaws. Although 
these images were more complex to be analysed successfully, they were not excluded 
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from this study as the striatal region was intact and also because this situation can occur 
in routine clinical DaTSCAN exams. 
The reference ROI is found following these steps: first, the registered image under study 
is smoothed with a Gaussian filter (16 mm full width at half maximum -FWHM); then it 
is binarized using a threshold level of 25% of the maximum level after smoothing; 
afterwards, a morphological erosion operation is carried out to shrink the binary ROI by 
approximately 16 mm on the top and around the head, in order to exclude the periphery 
of the head; finally, the volumes corresponding to the large ROIs over the striatum and 
the non-brain slices on the bottom of the head are removed (Figure 2). The width of the 
smoothing kernel, the threshold level, and the erosion operation were established 
experimentally and based on the authors’ knowledge, being some of these parameters 
similar to the ones used in previously published work [19]. The goal of these operations 
is to guarantee that only brain voxels are included in the reference ROI, as much as it is 
possible and/or feasible. Using this methodology, the reference ROI shrinks or enlarges 
accordingly to the content of the image. For instance, if the occipital cortex is partially 
cut, only the portion identified in the image will be included in the reference ROI. 
The ROIs of the caudate and putamen have predefined shapes (Figure 3) and are always 
placed in the same set of 9 mm thick slices in the middle of the striatum. In the transaxial 
plane, the caudate ROI is approximately an ellipse with the axes of 19 mm and 22 mm, 
and the putamen ROI has the same maximum width as the caudate but a length of 26 mm. 
The putamen ROI contains the putamen and globus pallidus. The shape of these ROIs and 
their inferior-superior position in the brain were established based on the SPECT 
template. Their placement and orientation on the axial plane can be adjusted accordingly 
with each image under study based on an optimization algorithm that chooses the 
placement and orientation to maximize total counts within the ROIs. To guarantee the 
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robustness of the ROI placements, even for images with very low specific uptake in the 
striatum, only small rotations relatively to the template are allowed. The ROIs defined for 
one of the sides move independently of the ROIs defined for the other side. For each side, 
the caudate and putamen ROIs move together. 
Computation of the uptake ratios 
The specific binding ratio (SBR) represents the ratio between the counts concentration in 
the striatum due to the specific binding only and the count concentration in the reference 
region due to the free and nonspecific binding [19]. For each side of the striatum, it is 
given by: 
R
VRCt
V
VSBR ROIROI
s
VX ´-´= , 
where sV  is the volume of the striatum, ROICt  is the total count in the large striatum ROI, 
R is the mean count per voxel within the reference ROI, ROIV  is the volume of the large 
striatum ROI in numbers of voxels, VXV  is the volume of a single voxel. Since it is 
impossible to assess the volume of the striatum for each person based on the [123I]FP-CIT 
SPECT brain image, a standard value of 2.11=sV  ml was used as in Tossici-Bolt et al 
[19]. 
The developed algorithm automatically computes the binding potential (BPND) at three 
specific regions: the caudate binding potential (CBP), the putamen binding potential 
(PBP), and the striatal binding potential (SBP). Following Innis et al [20], BPND refers to 
the ratio at equilibrium of specifically bound radioligands to that of nondisplaceable 
radioligands in tissue. Assuming a two-tissue compartment model: 
NDNDTND VVVBP /)( -= , where VT is the radioligands volume of distribution of the target 
region, and VND is the radioligands volume of distribution of the non-displaceable uptake. 
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VND is the sum of the volume of distribution of the free and non-specifically bound ligand. 
Since VT and VND are directly proportional to the counts per voxel of the target and 
reference regions, respectively, then RRCCBP /)( -= , RRPPBP /)( -= , and 
RRSSBP /)( -= , where C is the mean count per voxel in the caudate ROI, P is the mean 
count per voxel in the putamen ROI, S is the mean count per voxel in the striatum (here 
caudate and putamen ROIs), and R is the mean count per voxel within the reference 
region. The putamen to caudate ratio (PCR) is also computed and is given by 
)/()( CBPPBPPCR = . 
Dimensional analysis of the striatal uptake region 
As stated in the previous section, the binding potential can be defined at the voxel level 
as ( ) ( ) RRzyxIzyxBPND /),,(,, -= , where ),,( zyxI  is the count associated to the voxel 
with coordinates ),,( zyx , and R  is the mean count per voxel within the reference ROI. 
The BPND images are automatically built based on the registered images. As such, they 
can easily be used for comparison: intra-subject, inter-subjects, or a subject against the 
mean image of a reference population. Figure 4 shows an example of a BPND image built. 
The functional segmentation, i.e. extraction, of the region with uptake is performed on 
the BPND image, and is based on a threshold, or cut-off level, i.e. only voxels with a BPND 
higher than the cut-off level defined are included in the segmented region. After the initial 
cut-off, the binary image obtained is cleaned of scattered voxels by selecting only the 
larger group of connected voxels in each hemisphere. The total volume of the two sides 
of the segmented striatal region and the corresponding lengths are automatically 
calculated from the segmented image based on the orientation established for the template 
image (Figure 5). When there are no voxels with BPND greater than the cut-off level 
defined, the dimensional features are set to zero. It should be noted that the goal of the 
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implemented image segmentation process is not to extract the anatomical striatal region, 
as we are only carrying out a functional segmentation; on the contrary, we expect the 
extracted region to be significantly different from the anatomical region in individuals 
with PD. 
The optimal cut-off level is chosen based on the classification accuracy, i.e. the cut-off 
value that originates the best discrimination between HC and PD patients using the 
volume and length dimensional measures is chosen. 
Validation of the methodology 
The methodology was validated in two main aspects: the placement of the ROI and the 
classification accuracy using cross validation. The placement of the ROI was totally 
automatic, and visually examined by an expert just for quality control. To assess the 
classification accuracy, the well known leave-one-out cross validation (LOOCV) 
paradigm was used and three machine learning techniques were considered: linear SVM, 
LR and k-NN. 
Classification 
In this work, the classification problem is to decide if a [123I]FP-CIT brain image is from 
a subject with dopaminergic degeneration, i.e., PD or from a HC. The decision is based 
on a set of data for which the classification is known (training dataset). 
As the designation suggests, LOOCV method involves using the features from a single 
subject from the original dataset for validation, i.e. to be classified, and the remaining 
subjects as the training data. This procedure is repeated until all subjects are used once as 
validation data. Thus, for the dataset used, 652 training datasets are built (each one with 
651 subjects). Finally, comparing the gold standard diagnosis and the classification of 
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each subject using the LOOCV, the accuracy, sensitivity, and specificity of the 
classification model are estimated. 
The classification accuracy for the image dataset was assessed using each feature 
individually and three groups of features: a) uptake ratio-based features (SBR, CBP, PBP 
and PCR), b) dimensional-based features (volume and length) and c) the entire set of 
features altogether, i.e., a) plus b). In the uptake ratio-based group and all features group, 
the SBP was not included since it is a linear combination of the CBP and PBP features. 
With these feature-specific classification models, we assessed the potential of the features 
under study for classification, and thus gained more insights into the problem of [123I]FP-
CIT brain image classification. 
Two values of each feature are used for classification: one from the left side and the other 
from the right side of the brain. Thus, in practice, the dimension of each feature vector is 
twice the number of features used. 
Statistical analysis 
Statistical comparison among the mean values of the uptake ratios and dimensional 
features were assessed using t-tests. Statistical comparison among the accuracies obtained 
by the features individually and by the groups of features was done using the Cochran’s 
Q test followed by the pairwise post hoc Dunn's test with Bonferroni correction for 
multiple comparisons (padj). The statistical comparison was conducted using SPSS 20.0 
(SPSS Inc., Chicago, USA), and a significance level of 0.05 was established. 
Implementation 
The computational algorithm was fully implemented in C++ programming language and 
compiled using the compiler Microsoft Visual Studio 2008. The executable program built 
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by the compiler can run in any computer with the Windows operating system, without the 
need for any extra software package or hardware. We tested the program on a notebook 
PC with an Intel I7-2670QM microprocessor, 8 GB of RAM, and running Microsoft 
Windows 7. Techniques of image processing and visualization were partially 
implemented using the following free open source toolkits: The CImg Library, Insight 
Toolkit (ITK) [18] and Visualization Toolkit (VTK) [21], which allow compile the code 
to run on Linux or MAC operating systems. The tasks of learning and classification were 
partially implemented using the LIBSVM [22] and MATLAB R2014a (The MathWorks, 
USA). 
 
Results 
Robustness assessment 
The robustness of the methodology was assessed directly by visual inspection of the 
image registration and placement of the ROI. In terms of the image registration, in 
approximately 95% of the subjects, the image registration was adequate using the default 
parameters. For the other 5%, it was necessary a small change in the intensity 
normalization parameters. All ROI were adequately placed. 
Estimation of the optimal cut-off level for the functional segmentation 
To test which cut-off level is the best for the functional segmentation based on its ability 
to discriminate between HC and PD, we tested the BP cut-offs 1.0, 1.2, 1.4, 1.6, 1.8, and 
2.0. We have used only cut-off levels between 1.0 and 2.0 because cut-off levels inferior 
to 1.0 tend to include too many voxels that do not belong to the striatum, and cut-off 
levels superior to 2.0 tend to exclude too many voxels that belong to the striatum. As 
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shown in figure 6, the two best cut-off levels for the length are 1.4 and 1.6 without 
significant difference between them. The cut-off 1.6 gave rise to segmentation results in 
HC subjects visually more similar to the manual segmentations obtained by the experts 
and it is closer to the mean PBP in HC (Table 1), thus this value was chosen. 
Comparison of the uptake ratios and dimensional measures between groups 
The mean values for each feature computed from the entire dataset are presented in Table 
1. For all features there is a statistically significant difference between the values of the 
HC and the PD groups (t-test, p < 0.001). Healthy women have shown statistically 
significantly higher mean CBP, PBP, SBP and volume than healthy men (t-test: p = 0.002, 
p = 0.003, p = 0.008, respectively). 
Classification accuracy 
The classification accuracies, sensitivities and specificities obtained using each feature 
individually and the defined groups of features are shown in Table 2. The accuracies 
obtained using the three machine learning techniques are very similar and not 
significantly different among the machine learning techniques for most of the cases. 
However, for the feature SBR the accuracy obtained using the k-NN is significantly 
inferior than the accuracy obtained using the SVM (padj = 0.042) or Logistic Regression 
(padj = 0.001); for the length the accuracy obtained using the k-NN is significantly inferior 
to the accuracy obtained using the SVM (padj = 0.043); and for the set of all features the 
SVM originated an accuracy significantly superior to the accuracy obtained using the 
Logistic Regression (padj = 0.043). 
For all three classifiers, there was a statistically significant difference in the classification 
accuracies obtained from individual features (Cochran’s Q test, p < 0.001). The accuracy 
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obtained using the length was statistically significantly higher than using the SBR, CBP, 
PCR and volume (Table 3). Although the length has also achieved accuracies higher than 
the PBP and SBP (Table 2), the differences are not statistically significant (Table 3). The 
lower accuracies were obtained using the SBR and CBP, with no statistically significant 
difference between them (p > 0.091, padj = 1.000). 
Taking into account the defined groups of features, using the SVM classifier the accuracy 
obtained using the uptake ratio-based features is significantly inferior than the accuracies 
obtained using the dimensional features (p = 0.005, padj = 0.014) or all features (p < 0.001, 
padj = 0.001). There was not a statistically significant difference among these three groups 
of features using the k-NN (Cochran's Q test, p = 0.202) and LR (Cochran's Q test, p = 
0.078) classifiers. 
All images that appeared misclassified by the best classification model were examined 
and, based on the value of the features extracted, all the classifications obtained appeared 
to be, in fact, correct. However, since the PPMI classification was considered to be the 
gold standard, those classifications were regarded as incorrect classifications. 
Computer processing time 
In the notebook computer used, the mean total time necessary for the whole 
computational process to classify an image was about 10 seconds. This time includes all 
tasks, from image reading to classification. 
 
Discussion 
For all features under evaluation, a statistically significant difference was found between 
the mean values of the HC and PD groups (t-test, p < 0.001). Healthy women have shown 
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statistically significant higher mean CBP, PBP and SBP than healthy men. This is in 
agreement with the results found by Nobili et al [23] based on a database of the European 
Normal Control Database of DaTSCAN (ENC-DAT) study containing 139 [123I]FP-CIT 
SPECT scans of HC [24]. Likewise, the mean functional segmented volume in healthy 
women was also significantly higher than in healthy men. 
All features revealed good to very good discriminative power (minimum accuracy 
obtained was about 86%). The features that individually gave the best accuracy were the 
length and the PBP. It is not surprising that these two features gave rise to high 
classification accuracies, since it is known that, compared to HC subjects, there is a 
reduction of the [123I]FP-CIT uptake in the putamen of PD subjects, with a geometrical 
pattern of putamen caudal loss, leading to predictable decreases in length of the striatal 
region with a normal uptake. For all three classifiers, the length always originated the best 
accuracy, however the difference was not statistically significant when compared with 
the accuracies obtained using the PBP and SBP features. 
Although, at first glance, the length seems to be more vulnerable to artefacts and partial 
volume effects than the uptake ratio-based features, the solution that was adopted to 
compute its value proved to be sufficiently robust to be used in the computer assisted 
diagnosis of Parkinson’s disease. On the other hand, the length is easier to assess than the 
uptake ratios, as the PBP, for instance. Additionally, the uptake ratios are highly 
dependent on the delineation of the striatal ROIs. 
The volume of the striatal region with normal uptake originated high classification 
accuracies and better than the uptake ratio-based SBR and CBP, but not as good as the 
length and the PBP. 
It was a surprise that the group consisting of only the two dimensional-based features 
(length and volume) has achieved higher accuracies than the group of all uptake ratio-
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base features, although this difference was statistically significant only when the SVM 
classifier was used. This result shows the high potential of the dimensional-based features 
to be used in this kind of classification problems. 
Using all features simultaneously, a LOOCV classification accuracy of 97.9% (98.0% 
sensitivity, 97.6% specificity) was achieved using the SVM classifier. This result is 
remarkable since it was obtained from a large dataset of 652 images, and is highly 
competitive when compared with the ones reported in the literature. For instance, Koch 
et al [12] reported an accuracy close to 92% on a dataset of 155 images, and Tossici-Bolt 
et al [19] achieved an accuracy of 95% (97% sensitivity and 92% specificity) on a dataset 
of 55 images. It should be noted that, in both these latter cases, the accuracy was not 
validated via cross-validation. Using cross-validation and SVM based classifiers, 
Prashanth et al [14] found an accuracy of approximately 96% (96.6% sensitivity and 
95.0% specificity) on a PPMI dataset comprising well established pre-computed uptake 
ratios of 548 subjects. Using SVM and voxel-as-feature (VAF) approach, Illán et al [25] 
claimed an accuracy of approximately 91% (89% sensitivity and 93% specificity) on a 
dataset of 208 images, and Oliveira and Castelo-Branco [26] found an accuracy of 98% 
in a dataset from PPMI very similar to the one used here. 
In the developmental stage of this study, the gender and age of the subjects were also 
tested as additional features, but the classification accuracy remained unchanged. This 
result was not expected, since in healthy subjects of both genders there is a reduction of 
uptake in the caudate and putamen nucleus with age; besides women have a higher mean 
uptake than men (Table 1) [23]. May be we are facing some kind of ceiling effect, since 
the accuracies obtained are very close to 100%. 
For most of the features, there is no statistically significant differences among the 
accuracies obtained using the three machine learning techniques. This shows that the high 
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accuracy achieved is a consequence of the discrimination power of the features and not 
due to some particular aspect of the machine learning technique used. 
A small number of PD subjects were classified as HC, since the values of all their features 
were close, and sometimes higher than the mean values of the HC subjects. This was not 
totally unexpected since the classification made at the PPMI core was based on several 
clinical criteria plus the dopamine transporter images, while for our work the 
classification was based just on the dopamine transporter images results. 
In this work, a rigid geometric transformation was adopted in the image registration 
process. Although this option may be seen as a limitation, since the corrections for the 
size and shape of the subjects’ head were not addressed, it guarantees a more robust image 
registration process than if a non-rigid geometric transformation were to be used. This is 
because this kind of images has very low signal-to-noise ratio, low resolution and little 
anatomical information. Besides, the common standard Chang attenuation correction, 
which depends on the placement of an ellipse around the head on the transaxial slices, 
may significantly influence the apparent size and shape of the head, and consequently the 
image registration if non-rigid geometric transformations are used. Non-rigid registration 
is, therefore, not recommended whenever Chang attenuation correction is used. 
Whenever available, anatomical images (preferably MRI) of the patients' head should 
always be used for non-rigid registration algorithms. 
We used the whole brain (excluding a large ROI around the striatum) as reference region, 
as it was done in Tossici-Bolt et al [19], because it includes much higher number of voxels 
than the occipital or cerebellum. Thus it is less sensitivity to noise or artifacts. Besides, 
no significant changes in the uptake between healthy controls and patients are expected. 
In addition the specific uptake in the whole brain is very small comparatively to the 
striatum. When using the occipital region as reference, normal subjects showed higher 
20 
coefficient of variation (standard deviation / mean) for all indices in comparison with 
whole brain as reference. The cerebellum was not considered due to greater number of 
subjects with data acquisition that did not include entirely this region. 
The choice for the linear SVM, k-NN and LR classifiers was based on their popularity 
and good ability for many common classification problems. However, our intention was 
not to compare the classifiers, but the features used in the classification process. 
Naturally, an exhaustive search for other configurations of the parameters used in the 
extraction of the features or with the classifiers could lead to slightly different results. 
However, we strongly believe that our findings are robust to changes in the parameters. 
For Nuclear Medicine clinical sites where an anatomical image of the patient's head is 
available, for instance using a SPECT/CT, a more accurate delineation of the striatal 
nucleus can be done based on the anatomical image, and consequently improve the 
accuracy on the assessment of the binding potential. Also, in these cases, we recommend 
to normalize the functional length and volume features extracted from the [123I]FP-CIT 
by the length and volume measured in the anatomical images. 
To the best of our knowledge, this algorithm is the more complete quantitative evaluation 
of striatal dopaminergic features so far available. The use of the new dimensional-based 
features in combination with the standard features based on uptake ratios may enable 
nuclear medicine experts to improve the accuracy of their diagnostic imaging skills. Other 
main clinically useful applications of this algorithm are: (a) improvement in inter- and 
intra-rater diagnostic (pre-synaptic dopaminergic degeneration) agreement; (b) 
implementation of multivariate quantitative analysis for easier integration into more 
modern diagnostic automatic criteria; (c) higher discriminative power with some difficult 
cases; (d) useful as a training tool; (e) quantification of disease evolution from early 
poorly symptomatic to more symptomatic cases; (f) assessment of efficacy of new 
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treatments that may delay the disease evolution; (g) quality control in busy nuclear 
medicine services, since a disagreement between the physician visual evaluation and the 
machine learning output imply more careful re-evaluation of the entire study. 
The dataset used in our study contains only patients diagnosed with idiopathic Parkinson's 
disease and healthy controls. Thus, the results cannot be extrapolated to other pre-synaptic 
dopaminergic neuronal loss diseases without further evaluation. Although the diagnosis 
of idiopathic Parkinson's disease has been made using the most rigorous clinical criteria, 
the lack of post mortem diagnosis confirmation is, no doubt, a limitation of this study. 
In conclusion, when the semi-quantitative ratios and the dimensional-based features are 
combined there is a statistically significant increase in the classification accuracy in 
comparison with methods using just the semi-quantitative ratios (SVM classifier, Dunn's 
test with Bonferroni correction padj < 0.001). The high accuracy obtained using all features 
under evaluation simultaneously, was not a consequence of the classifier used, but an 
outcome of the features selected. In addition, generalization can be expected because the 
results were obtained using a considerably large dataset with a fully automated 
computational algorithm. The results showed that the length of the striatal uptake region 
revealed clinical added value, since the accuracy obtained was slightly higher than the 
best accuracy achieved by the standard uptake ratio-based features (PBP and SBP). In 
addition, it is easier to assess. Thus, we believe that it should be implemented in the 
computer-aided confirmation "in vivo" of dopaminergic degeneration with [123I]FP-CIT 
SPECT investigations. 
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FIGURE CAPTIONS 
 
 
Fig. 1 Flow diagram for the quantification of a [123I]FP-CIT SPECT brain image 
 
Fig. 2 Visualization on axial, coronal and sagittal planes of the striatal large ROI and 
reference ROI defined on an example image 
 
Fig. 3 The 3D ROIs defined on the caudate and putamen of an example image in the axial, 
coronal and sagittal planes 
 
Fig. 4 Example of a BPND image built from a HC subject: On the left, an axial slice is 
visible; middle top, a coronal slice; middle bottom, a sagittal slice; and on the right, the 
dimensionless BPND colour scale used (only voxels with a positive BPND are shown) 
 
Fig. 5 Example of the segmented region with normal uptake obtained from an HC subject. 
The arrows indicate the directions defined for measuring the length 
 
Fig. 6 Variation of the LOOCV accuracy as a function of the segmentation cut-off level 
and using a SVM classifier 
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TABLE CAPTIONS 
Table 1 Mean and standard-deviation values of each feature obtained from the four 
groups of subjects included in the experimental dataset 
Table 2 Results of the cross-validation accuracy (Acc.), sensitivity (Sen.), specificity 
(Spe.) for the three classifiers tested using the LOOCV approach (values are in 
percentage) 
Table 3 P-values for pairwise comparison among the accuracy obtained using the length 
against the accuracies obtained using the other features (padj is the p value corrected for 
multiple comparisons) 
 
  
27 
FIGURES 
 
 
 
Figure 1 
 
28 
 
 
Figure 2 
 
29 
 
 
Figure 3 
 
 
 
Figure 4 
 
30 
 
Figure 5 
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TABLES 
Table 1 
Feature Control female PD female Control male PD male 
SBR 6.19±1.30 4.00±1.06 5.88±1.23 3.89±1.00 
CBP 2.47±0.44 1.62±0.41 2.29±0.31 1.54±0.41 
PBP 1.84±0.41 0.87±0.27 1.67±0.37 0.81±0.23 
SBP 2.14±0.41 1.22±0.32 1.96±0.37 1.15±0.30 
PCR 0.74±0.07 0.53±0.08 0.72±0.08 0.53±0.08 
Volume [ml] 11.0±4.0 3.4±2.6 9.5±3.7 2.8±2.4 
Length [mm] 36.3±4.9 17.0±7.4 34.9±5.6 15.9±7.5 
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Table 2 
Features used SVM classifier KNN classifier LR classifier 
 Acc. Sen. Spe. Acc. Sen. Spe. Acc. Sen. Spe. 
SBR 88.8 92.3 81.3 87.1 91.2 78.5 89.6 93.5 81.3 
CBP 88.2 89.8 84.7 86.7 88.3 83.3 87.7 91.2 80.4 
PBP 95.4 96.8 92.3 95.6 96.2 94.3 95.1 97.3 90.4 
SBP 93.9 95.0 91.4 94.2 95.3 91.9 94.0 95.9 90.0 
PCR 92.0 93.7 88.5 91.1 92.3 88.5 91.4 93.9 86.1 
Volume 92.0 94.1 87.6 92.0 93.5 89.0 92.5 95.3 86.6 
Length 96.5 97.5 94.3 96.0 97.5 92.8 96.6 97.7 94.3 
Uptake ratio-based 96.3 97.5 93.8 96.6 97.3 95.2 96.6 97.5 94.7 
Dimensional-based 97.5 97.7 97.1 97.2 97.3 97.1 97.5 97.7 97.1 
All features 97.9 98.0 97.6 97.2 97.5 96.7 96.9 97.7 95.2 
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Table 3 
Classifiers Features 
 SBR CBP PBP SBP PCR Volume 
SVM p < 0.001, padj < 0.001 
p < 0.001, 
padj < 0.001 
p = 0.324, 
padj = 1.0 
p = 0.017, 
padj = 0.347 
p < 0.001, 
padj = 0.001 
p < 0.001, 
padj = 
0.001 
k-NN p < 0.001, padj < 0.001 
p < 0.001, 
padj < 0.001 
p = 0.696, 
padj = 1.0 
p = 0.118, 
padj = 1.0 
p < 0.001, 
padj = 0.001 
p = 0.001, 
padj = 
0.015 
LR p < 0.001, padj < 0.001 
p < 0.001, 
padj < 0.001 
p = 0.696, 
padj = 1.0 
p = 0.118, 
padj = 1.0 
p < 0.001, 
padj = 0.001 
p = 0.001, 
padj = 
0.015 
 
 
